High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

被引：0
|
作者：
Galligioni, E [1 ]
Cetto, G [1 ]
Nascimben, O [1 ]
Buonadaona, A [1 ]
Crivellari, D [1 ]
Molino, A [1 ]
Veronesi, A [1 ]
Graiff, C [1 ]
Barni, S [1 ]
Puccetti, C [1 ]
Ferrazzi, E [1 ]
Recaldin, E [1 ]
Sava, C [1 ]
Saracchini, S [1 ]
Sacco, C [1 ]
机构：
[1] Ctr Riferimento Oncol, GOCCNE, I-33081 Aviano, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89301-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P84
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [21] Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer
    Sitzia, J
    Huggins, L
    CANCER PRACTICE, 1998, 6 (01) : 13 - 21
  • [22] Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer
    Paradiso, A
    Schittulli, F
    Cellamare, G
    Mangia, A
    Marzullo, F
    Lorusso, V
    De Lena, M
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3929 - 3937
  • [23] A CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST-CANCER
    HOWELL, A
    RUBENS, RD
    BUSH, H
    GEORGE, WD
    HOWAT, JMT
    CROWTHER, D
    SELLWOOD, RA
    HAYWARD, JL
    KNIGHT, RK
    BULBROOK, RD
    FENTIMAN, IS
    CHAUDARY, M
    RECENT RESULTS IN CANCER RESEARCH, 1984, 96 : 74 - 89
  • [24] Comparison of CVF (Cyclophosphamide plus Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide plus Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
    Gwak, Geumhee
    Park, Kyeongmee
    Shin, Eunah
    Han, Sehwan
    Kim, Ji-Young
    Kim, Hongyong
    Kim, Young Duk
    Kim, Hong Ju
    Kim, Ki Whan
    Bae, Byung Noe
    Yang, Keun Ho
    Cho, Hyunjin
    Park, Sung-Jin
    JOURNAL OF BREAST CANCER, 2011, 14 (03) : 223 - 228
  • [25] Hepatic toxicity during adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) in breast cancer
    Noberasco, C
    Peruzzotti, G
    Colleoni, M
    Nole, F
    deBraud, F
    Martinelli, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [26] EPIRUBICIN (E) FOLLOWED BY CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) VERSUS PACLITAXEL (T) FOLLOWED BY EPIRUBICIN AND VINORELBINE (EV) IN PATIENTS WITH HIGH-RISK OPERABLE BREAST CANCER
    Guglielmini, Pamela
    Sismondi, Piero
    Farris, Antonio
    Amadori, Dino
    Agostara, Biagio
    Gambi, Angelo
    Catalano, Giuseppina
    Faedi, Marina
    Rubagotti, Alessandra
    Boccardo, Francesco
    ANNALS OF ONCOLOGY, 2009, 20
  • [27] Influence of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil on plasma melatonin and chosen hormones in breast cancer premenopausal patients
    Kajdaniuk, D
    Marek, B
    Kos-Kudla, B
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (04) : 297 - 301
  • [28] PROSPECTIVE EVALUATION OF CHRONIC CARDIOTOXICITY DUE TO HIGH-DOSE EPIRUBICIN OR COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL
    HAVSTEEN, H
    BRYNJOLF, I
    SVAHN, T
    DOMBERNOWSKY, P
    GODTFREDSEN, J
    MUNCK, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (02) : 101 - 104
  • [29] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE OR CMF IN PREMENOPAUSAL WOMEN WITH STAGE-II BREAST-CANCER
    BRINCKER, H
    MOURIDSEN, HT
    ANDERSEN, KW
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (01) : 91 - 95
  • [30] Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer
    Hoy, Julia
    Neeman, Teresa
    Stuart-Harris, Robin
    Davis, Alison
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 129 - 136
12345